Posted on March 14th, 2016 by msequeira
The “Ride for the Cure NM” event will begin with a motorcycle ride from Tijeras and end in Edgewood.
The annual motorcycle ride will raise money for the University of New Mexico Comprehensive Cancer Center. The money helps New Mexicans fighting cancer and supports cancer research at the UNM Cancer Center. The ride was started ten years ago with just 12 riders and has grown to include more than 1,000.
This year’s ride will run from Molly’s Bar in Tijeras to the Wildlife West Nature Park in Edgewood. The event in Edgewood will feature food, shopping and music. Entrance to the Nature Park will also be available for a $5 entry fee.
Saturday, March 26, 2016.
Registration opens at 9:30 a.m., ride begins at 10:30 a.m.
Ride will start at Molly’s Bar, 546 State Hwy 333 Tijeras, NM 87059.
Ride ends at Wildlife West Nature Park, 87 North Frontage Road, Edgewood, NM 87015.
Gina Felix, Ride for the Cure NM, 505-315-6588
Dorothy Hornbeck, JKPR, 505-340-5929, email@example.com
The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 400-mile radius. One of the premier cancer centers nationwide, the UNM CCC has 128 board-certified oncology physicians, forming New Mexico’s largest cancer care team. It treats about 60 percent of adults and virtually all the children in New Mexico diagnosed with cancer — more than 10,000 people— from every county in the state in more than 135,000 clinic visits each year. Through its partnership with the New Mexico Cancer Care Alliance, an “exemplary national model for cancer health care delivery,” the UNM CCC offers access to more than 160 clinical trials to New Mexicans in every part of the state. Annual research funding of more than $72 million supports the UNM CCC’s 132 cancer scientists. Working with partners at Los Alamos and Sandia National Laboratories, Lovelace Respiratory Research Institute, and New Mexico State University, they have developed new diagnostics and drugs for leukemia, breast cancer, ovarian cancer, prostate cancer, liver and pancreatic cancer, brain cancer, and melanoma; garnered 33 new patents and 117 patents pending; and launched 13 new biotechnology companies since 2010. Learn more at http://www.cancer.unm.edu.
You must be logged-in to the site to post a comment.